A breakthrough in treating inherited retinal dystrophies, including some forms of RP, is gene therapy with Luxturna (voretigene neparvovec-rzyl), targeted at mutations in the RPE65 gene. The gene discussed is RPE65; the disease is retinitis pigmentosa 1.